Next-Gen Cancer Antibody Technology from Germany enters the Clinic
Apogenix' partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the…
April 13, 2017 - 2 minutes
Apogenix' partner AbbVie has started the first clinical trial for an immuno-oncology candidate with the…
From leukemia to multiple myeloma, biotech is working hard to cure blood cancer. This year's…
Apogenix's lead candidate APG101, which has shown great results in a phase II study to…